10–28–09 Vol. 74 No. 207 Wednesday Oct. 28

Total Page:16

File Type:pdf, Size:1020Kb

10–28–09 Vol. 74 No. 207 Wednesday Oct. 28 10–28–09 Wednesday Vol. 74 No. 207 Oct. 28, 2009 Pages 55437–55744 VerDate Nov 24 2008 19:07 Oct 27, 2009 Jkt 220001 PO 00000 Frm 00001 Fmt 4710 Sfmt 4710 E:\FR\FM\28OCWS.LOC 28OCWS jlentini on DSKJ8SOYB1PROD with FRWS II Federal Register / Vol. 74, No. 207 / Wednesday, October 28, 2009 The FEDERAL REGISTER (ISSN 0097–6326) is published daily, SUBSCRIPTIONS AND COPIES Monday through Friday, except official holidays, by the Office of the Federal Register, National Archives and Records PUBLIC Administration, Washington, DC 20408, under the Federal Register Subscriptions: Act (44 U.S.C. Ch. 15) and the regulations of the Administrative Paper or fiche 202–512–1800 Committee of the Federal Register (1 CFR Ch. I). The Assistance with public subscriptions 202–512–1806 Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402 is the exclusive distributor of the official General online information 202–512–1530; 1–888–293–6498 edition. Periodicals postage is paid at Washington, DC. Single copies/back copies: The FEDERAL REGISTER provides a uniform system for making Paper or fiche 202–512–1800 available to the public regulations and legal notices issued by Assistance with public single copies 1–866–512–1800 Federal agencies. These include Presidential proclamations and (Toll-Free) Executive Orders, Federal agency documents having general FEDERAL AGENCIES applicability and legal effect, documents required to be published by act of Congress, and other Federal agency documents of public Subscriptions: interest. Paper or fiche 202–741–6005 Documents are on file for public inspection in the Office of the Assistance with Federal agency subscriptions 202–741–6005 Federal Register the day before they are published, unless the issuing agency requests earlier filing. For a list of documents FEDERAL REGISTER WORKSHOP currently on file for public inspection, see www.federalregister.gov. The seal of the National Archives and Records Administration THE FEDERAL REGISTER: WHAT IT IS AND HOW TO USE IT authenticates the Federal Register as the official serial publication FOR: Any person who uses the Federal Register and Code of established under the Federal Register Act. Under 44 U.S.C. 1507, Federal Regulations. the contents of the Federal Register shall be judicially noticed. The Federal Register is published in paper and on 24x microfiche. WHO: Sponsored by the Office of the Federal Register. It is also available online at no charge as one of the databases WHAT: Free public briefings (approximately 3 hours) to present: on GPO Access, a service of the U.S. Government Printing Office. 1. The regulatory process, with a focus on the Federal The online edition of the Federal Register www.gpoaccess.gov/ Register system and the public’s role in the develop- nara, available through GPO Access, is issued under the authority of the Administrative Committee of the Federal Register as the ment of regulations. official legal equivalent of the paper and microfiche editions (44 2. The relationship between the Federal Register and U.S.C. 4101 and 1 CFR 5.10). It is updated by 6 a.m. each day Code of Federal Regulations. the Federal Register is published and includes both text and graphics from Volume 59, Number 1 (January 2, 1994) forward. 3. The important elements of typical Federal Register doc- uments. For more information about GPO Access, contact the GPO Access User Support Team, call toll free 1-888-293-6498; DC area 202- 4. An introduction to the finding aids of the FR/CFR sys- 512-1530; fax at 202-512-1262; or via e-mail at [email protected]. tem. The Support Team is available between 7:00 a.m. and 9:00 p.m. WHY: To provide the public with access to information nec- Eastern Time, Monday–Friday, except official holidays. essary to research Federal agency regulations which di- The annual subscription price for the Federal Register paper rectly affect them. There will be no discussion of spe- edition is $749 plus postage, or $808, plus postage, for a combined cific agency regulations. Federal Register, Federal Register Index and List of CFR Sections Affected (LSA) subscription; the microfiche edition of the Federal llllllllllllllllll Register including the Federal Register Index and LSA is $165, plus postage. Six month subscriptions are available for one-half WHEN: Tuesday, November 10, 2009 the annual rate. The prevailing postal rates will be applied to 9 a.m.–12:30 p.m. orders according to the delivery method requested. The price of a single copy of the daily Federal Register, including postage, WHERE: Office of the Federal Register is based on the number of pages: $11 for an issue containing Conference Room, Suite 700 less than 200 pages; $22 for an issue containing 200 to 400 pages; 800 North Capitol Street, NW. and $33 for an issue containing more than 400 pages. Single issues of the microfiche edition may be purchased for $3 per copy, Washington, DC 20002 including postage. Remit check or money order, made payable RESERVATIONS: (202) 741–6008 to the Superintendent of Documents, or charge to your GPO Deposit Account, VISA, MasterCard, American Express, or Discover. Mail to: U.S. Government Printing Office—New Orders, P.O. Box 979050, St. Louis, MO 63197-9000; or call toll free 1- 866-512-1800, DC area 202-512-1800; or go to the U.S. Government Online Bookstore site, see bookstore.gpo.gov. There are no restrictions on the republication of material appearing in the Federal Register. How To Cite This Publication: Use the volume number and the page number. Example: 74 FR 12345. Postmaster: Send address changes to the Superintendent of Documents, Federal Register, U.S. Government Printing Office, Washington, DC 20402, along with the entire mailing label from the last issue received. VerDate Nov 24 2008 19:07 Oct 27, 2009 Jkt 220001 PO 00000 Frm 00002 Fmt 4710 Sfmt 4710 E:\FR\FM\28OCWS.LOC 28OCWS jlentini on DSKJ8SOYB1PROD with FRWS III Contents Federal Register Vol. 74, No. 207 Wednesday, October 28, 2009 Agriculture Department Energy Department See Grain Inspection, Packers and Stockyards See Federal Energy Regulatory Commission Administration See National Institute of Food and Agriculture Environmental Protection Agency See Natural Resources Conservation Service RULES NOTICES Exemption from the Requirement of a Tolerance: Agency Information Collection Activities; Proposals, Cold Pressed Neem Oil, 55458–55463 Submissions, and Approvals, 55536 Ulocladium oudemansii (U3 Strain), 55454–55458 National Emission Standards for Hazardous Air Pollutants Centers for Disease Control and Prevention From Petroleum Refineries, 55670–55692 NOTICES Pesticide Tolerances: Agency Information Collection Activities; Proposals, Pyriproxyfen, 55463–55467 Submissions, and Approvals, 55559–55562 PROPOSED RULES Meetings: Amendment to the Opt-out and Recordkeeping Provisions Health Disparities Subcommittee, Advisory Committee to in the Renovation, Repair, and Painting Program: the Director; Correction, 55566–55567 Lead, 55506–55524 Healthcare Infection Control Practices Advisory National Emission Standards for Hazardous Air Pollutants Committee, 55567 From Petroleum Refineries, 55505–55506 NOTICES Centers for Medicare & Medicaid Services Proposed Consent Decree, Clean Air Act Citizen Suit, NOTICES 55547–55548 Agency Information Collection Activities; Proposals, Request for Nominations of Experts: Submissions, and Approvals, 55559 Clean Air Scientific Advisory Committee Lead Review Commerce Department Panel, 55548–55549 See International Trade Administration Executive Office for Immigration Review See National Institute of Standards and Technology RULES See National Oceanic and Atmospheric Administration Application of Immigration Regulations to the Consumer Product Safety Commission Commonwealth of the Northern Mariana Islands, PROPOSED RULES 55726–55744 Standard for Recreational Off-Highway Vehicles, 55495– 55499 Executive Office of the President See Presidential Documents Drug Enforcement Administration PROPOSED RULES Federal Accounting Standards Advisory Board Registration Requirements for Individual Practitioners NOTICES Operating in a ‘‘Locum Tenens’’ Capacity, 55499–55502 AICPA Statements on Auditing Standards: Schedules of Controlled Substances: Codification of Accounting and Financial Reporting Placement of 5–Methoxy–N,N–Dimethyltryptamine into Standards, 55551–55552 Schedule I of the Controlled Substances Act, 55502– 55504 Federal Aviation Administration NOTICES RULES Importer of Controlled Substances; Applications, 55583– Airworthiness Directives: 55585 Eurocopter France (ECF) Model EC 155B and EC155B1 Importer of Controlled Substances; Registrations, 55585– Helicopters, 55447–55449 55586 Establishment of Class E Airspace: Manufacturer of Controlled Substances; Applications, Nantucket, MA, 55449 55586–55588 Modification of Class E Airspace: Manufacturer of Controlled Substances; Registrations, Anniston, AL, 55449–55451 55588–55591 Special Conditions: Bombardier Model Challenger CL–600–2B16 (CL–605, Education Department Ref. Note 9 of TC No. A21EA); Enhanced Flight RULES Vision System, 55443–55447 Institutions and Lender Requirements Relating to Education Standard Instrument Approach Procedures, and Takeoff Loans, Student Assistance General Provisions, et al., Minimums and Obstacle Departure Procedures; 55626–55668 Miscellaneous Amendments, 55451–55454 NOTICES PROPOSED RULES Federal Student Financial Assistance Programs under Title Airworthiness Directives: IV of the Higher Education Act of 1965, as Amended, Airbus Model A300 B4–2C, B4–103, and
Recommended publications
  • 8–21–09 Vol. 74 No. 161 Friday Aug. 21, 2009 Pages 42169–42572
    8–21–09 Friday Vol. 74 No. 161 Aug. 21, 2009 Pages 42169–42572 VerDate Nov 24 2008 21:37 Aug 20, 2009 Jkt 217001 PO 00000 Frm 00001 Fmt 4710 Sfmt 4710 E:\FR\FM\21AUWS.LOC 21AUWS srobinson on DSKHWCL6B1PROD with MISCELLANEOUS II Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 The FEDERAL REGISTER (ISSN 0097–6326) is published daily, SUBSCRIPTIONS AND COPIES Monday through Friday, except official holidays, by the Office of the Federal Register, National Archives and Records PUBLIC Administration, Washington, DC 20408, under the Federal Register Subscriptions: Act (44 U.S.C. Ch. 15) and the regulations of the Administrative Paper or fiche 202–512–1800 Committee of the Federal Register (1 CFR Ch. I). The Assistance with public subscriptions 202–512–1806 Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402 is the exclusive distributor of the official General online information 202–512–1530; 1–888–293–6498 edition. Periodicals postage is paid at Washington, DC. Single copies/back copies: The FEDERAL REGISTER provides a uniform system for making Paper or fiche 202–512–1800 available to the public regulations and legal notices issued by Assistance with public single copies 1–866–512–1800 Federal agencies. These include Presidential proclamations and (Toll-Free) Executive Orders, Federal agency documents having general FEDERAL AGENCIES applicability and legal effect, documents required to be published by act of Congress, and other Federal agency documents of public Subscriptions: interest. Paper or fiche 202–741–6005 Documents are on file for public inspection in the Office of the Assistance with Federal agency subscriptions 202–741–6005 Federal Register the day before they are published, unless the issuing agency requests earlier filing.
    [Show full text]
  • Activation of 5-HT2C (But Not 5-HT1A) Receptors in the Amygdala Enhances Fear-Induced Antinociception: Blockade with Local 5-HT2C Antagonist Or Systemic fluoxetine
    Neuropharmacology 135 (2018) 376e385 Contents lists available at ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm Activation of 5-HT2C (but not 5-HT1A) receptors in the amygdala enhances fear-induced antinociception: Blockade with local 5-HT2C antagonist or systemic fluoxetine Lígia Renata Rodrigues Tavares a, b, Daniela Baptista-de-Souza a, c, * Azair Canto-de-Souza a, b, c, d, a Psychobiology Group, Department of Psychology/CECH- Federal University of Sao~ Carlos-UFSCar, Sao~ Carlos, Sao~ Paulo, 13565-905, Brazil b Joint Graduate Program in Physiological Sciences UFSCar/UNESP, Sao~ Carlos, Sao~ Paulo, 13565-905, Brazil c Neuroscience and Behavioral Institute-IneC, Ribeirao~ Preto, Sao~ Paulo, 14040-901, Brazil d Program in Psychology UFSCar, Sao~ Carlos, Sao~ Paulo, 13565-905, Brazil article info abstract Article history: It is well-known that the exposure of rodents to threatening environments [e.g., the open arm of the Received 17 August 2017 elevated-plus maze (EPM)] elicits pain inhibition. Systemic and/or intracerebral [e.g., periaqueductal gray Received in revised form matter, amygdala) injections of antiaversive drugs [e.g., serotonin (5-HT) ligands, selective serotonin 5 March 2018 reuptake inhibitors (SSRIs)] have been used to change EPM-open arm confinement induced anti- Accepted 6 March 2018 nociception (OAA). Here, we investigated (i) the role of the 5-HT and 5-HT receptors located in the Available online 13 March 2018 1A 2C amygdaloid complex on OAA as well as (ii) the effects of systemic pretreatment with fluoxetine (an SSRI) on the effects of intra-amygdala injections of 8-OH-DPAT (a 5-HT1A agonist) or MK-212 (a 5-HT2C agonist) Keywords: fi Amygdala on nociception in mice con ned to the open arm or enclosed arm of the EPM.
    [Show full text]
  • Synthesis of Serotonergic Agents
    SYNTHESIS OF SEROTONERGIC AGENTS A Thesis Presented by PARVIZ GHARAGOZLOO According to the Requirements o f the University of London for the Degree of DOCTOR OF PHILOSOPHY Attention is drawn to the fact that copyright of this thesis rests with its author. This copy of the thesis has been supplied on condition that anyone who consults it, is understood to recognise that the copyright rests with its author and that no quotation from the thesis and no information derived from it may be published without prior consent of the author. Signature: Date: Department of Chemistry, University College London, December 1991 London. ProQuest Number: 10797729 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 10797729 Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 To those whom I love and so greatly miss ACKNOWLEDGMENTS I wish to express my sincere thanks to Professor C. R. Ganellin for suggesting and supervising the serotonin project. I am also deeply indebted to him for his continuous encouragement, guidance, enthusiasm and friendship throughout this work.
    [Show full text]
  • Tryptophan Metabolism: Implications for Biological Processes, Health and Disease Molecular and Integrative Toxicology
    Molecular and Integrative Toxicology Atilla Engin Ayse Basak Engin Editors Tryptophan Metabolism: Implications for Biological Processes, Health and Disease x Contributors Nilufer Guler , M.D. Professor Emeritus, Department of Medical Oncology , Hacettepe Univesity Institute of Oncology , Ankara , Turkey Ibrahim C. Haznedaroglu , M.D. Department of Hematology , Hacettepe University, Medical School , Ankara , Turkey Hiroyasu Ito , M.D., Ph.D. Department of Informative Clinical Medicine , Gifu University Graduate School of Medicine , Gifu City , Japan Asiye Kanbay , M.D. Faculty of Medicine, Department of Pulmonary Medicine , Istanbul Medeniyet University , Kadıköy, Istanbul , Turkey S. Altug Kesikli , M.D., Ph.D. Department of Basic Oncology, Hacettepe University Cancer Institute, Altindag, Ankara, Turkey Heinz Kofl er , M.D. Allergy Ambulance , Hall , Austria Oguz Kokturk , M.D. Faculty of Medicine, Department of Pulmonary Medicine, Sleep Disorders Center , Gazi University , Beşevler, Ankara , Turkey Yuki Murakami , Ph.D. Human Health Sciences, Graduate School of Medicine and Faculty of Medicine , Kyoto University , Sakyo-Ku , Kyoto , Japan Natividad Olivar , M.D. Centro de Neuropsiquiatría y Neurología de la Conducta, Hospital de Clínicas “José de San Martín”, Facultad de Medicina , Universidad de Buenos Aires , Buenos Aires , Argentina Gregory Oxenkrug , M.D., Ph.D. Neuroinfl ammation Program, Department of Psychiatry , Tufts Medical Center and Tufts University School of Medicine , Boston , MA , USA Kuniaki Saito , Ph.D. Human Health Sciences, Graduate School of Medicine and Faculty of Medicine , Kyoto University , Sakyo-Ku , Kyoto , Japan Ugur Unluturk, M.D. Department of Endocrinology and Metabolism , Kirklareli State Hospital , Kirklareli , Turkey María F. Vidal , M.D. Departamento de Docencia e Investigación, Facultad de Ciencias Médicas , Pontifi cia Universidad Católica Argentina , Buenos Aires , Argentina Daniel E.
    [Show full text]
  • Serotonin and Brain Function: a Tale of Two Receptors
    JOP0010.1177/0269881117725915Journal of PsychopharmacologyCarhart-Harris and Nutt 725915review-article2017 Review Serotonin and brain function: a tale of two receptors Journal of Psychopharmacology 1 –30 © The Author(s) 2017 RL Carhart-Harris and DJ Nutt Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI:https://doi.org/10.1177/0269881117725915 10.1177/0269881117725915 journals.sagepub.com/home/jop Abstract Previous attempts to identify a unified theory of brain serotonin function have largely failed to achieve consensus. In this present synthesis, we integrate previous perspectives with new and older data to create a novel bipartite model centred on the view that serotonin neurotransmission enhances two distinct adaptive responses to adversity, mediated in large part by its two most prevalent and researched brain receptors: the 5-HT1A and 5-HT2A receptors. We propose that passive coping (i.e. tolerating a source of stress) is mediated by postsynaptic 5-HT1AR signalling and characterised by stress moderation. Conversely, we argue that active coping (i.e. actively addressing a source of stress) is mediated by 5-HT2AR signalling and characterised by enhanced plasticity (defined as capacity for change). We propose that 5-HT1AR-mediated stress moderation may be the brain’s default response to adversity but that an improved ability to change one’s situation and/or relationship to it via 5-HT2AR-mediated plasticity may also be important – and increasingly so as the level of adversity reaches a critical point. We propose that the 5HT1AR pathway is enhanced by conventional 5-HT reuptake blocking antidepressants such as the selective serotonin reuptake inhibitors (SSRIs), whereas the 5-HT2AR pathway is enhanced by 5-HT2AR-agonist psychedelics.
    [Show full text]
  • 5–21–09 Vol. 74 No. 97 Thursday May 21, 2009 Pages 23789–23936
    5–21–09 Thursday Vol. 74 No. 97 May 21, 2009 Pages 23789–23936 VerDate Nov 24 2008 17:34 May 20, 2009 Jkt 217001 PO 00000 Frm 00001 Fmt 4710 Sfmt 4710 E:\FR\FM\21MYWS.LOC 21MYWS mstockstill on PROD1PC66 with FEDREGWS II Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 The FEDERAL REGISTER (ISSN 0097–6326) is published daily, SUBSCRIPTIONS AND COPIES Monday through Friday, except official holidays, by the Office of the Federal Register, National Archives and Records PUBLIC Administration, Washington, DC 20408, under the Federal Register Subscriptions: Act (44 U.S.C. Ch. 15) and the regulations of the Administrative Paper or fiche 202–512–1800 Committee of the Federal Register (1 CFR Ch. I). The Assistance with public subscriptions 202–512–1806 Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402 is the exclusive distributor of the official General online information 202–512–1530; 1–888–293–6498 edition. Periodicals postage is paid at Washington, DC. Single copies/back copies: The FEDERAL REGISTER provides a uniform system for making Paper or fiche 202–512–1800 available to the public regulations and legal notices issued by Assistance with public single copies 1–866–512–1800 Federal agencies. These include Presidential proclamations and (Toll-Free) Executive Orders, Federal agency documents having general FEDERAL AGENCIES applicability and legal effect, documents required to be published by act of Congress, and other Federal agency documents of public Subscriptions: interest. Paper or fiche 202–741–6005 Documents are on file for public inspection in the Office of the Assistance with Federal agency subscriptions 202–741–6005 Federal Register the day before they are published, unless the issuing agency requests earlier filing.
    [Show full text]
  • Committee Meeting Expanded Agenda
    2016 Regular Session The Florida Senate COMMITTEE MEETING EXPANDED AGENDA REGULATED INDUSTRIES Senator Bradley, Chair Senator Margolis, Vice Chair MEETING DATE: Wednesday, January 27, 2016 TIME: 9:00—11:00 a.m. PLACE: Toni Jennings Committee Room, 110 Senate Office Building MEMBERS: Senator Bradley, Chair; Senator Margolis, Vice Chair; Senators Abruzzo, Bean, Braynon, Diaz de la Portilla, Flores, Latvala, Negron, Richter, Sachs, and Stargel BILL DESCRIPTION and TAB BILL NO. and INTRODUCER SENATE COMMITTEE ACTIONS COMMITTEE ACTION 1 SB 1602 Elevators; Creating the "Maxwell Erik 'Max' Grablin Fav/CS Galvano Act"; providing clearance requirements for elevators Yeas 9 Nays 0 (Identical H 1289) installed in residential dwellings; requiring all such elevators to be equipped with a certain sensor device, etc. RI 01/27/2016 Fav/CS CA FP 2 SB 1528 Illicit Drugs; Revising the circumstances under which Fav/CS Simpson the Division of Alcoholic Beverages and Tobacco of Yeas 9 Nays 0 (Identical H 1347) the Department of Business and Professional Regulation may revoke or suspend a person’s license; requiring the division to suspend the license of an establishment licensed under the Beverage Law under certain circumstances, etc. RI 01/27/2016 Fav/CS ACJ AP 3 SB 768 Alarm System Registration; Providing a uniform Fav/CS Flores process for the registration of home and business Yeas 10 Nays 0 (Similar CS/H 779) alarm systems under certain circumstances; requiring the owner, lessee, or occupant, or an authorized representative thereof, of a property to register an alarm system within 20 days after occupancy or after installation of the alarm system; authorizing the applicable local governmental entity to assess or impose fines or penalties for a failure to register an alarm system or for excessive false alarms, etc.
    [Show full text]
  • Ep 0858996 B1
    Europäisches Patentamt *EP000858996B1* (19) European Patent Office Office européen des brevets (11) EP 0 858 996 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C07D 209/90, C07D 401/04, of the grant of the patent: C07D 491/06, A61K 31/40, 27.10.2004 Bulletin 2004/44 A61K 31/445, A61K 31/495, (21) Application number: 97924254.2 A61K 31/535 (22) Date of filing: 29.05.1997 (86) International application number: PCT/JP1997/001828 (87) International publication number: WO 1997/045410 (04.12.1997 Gazette 1997/52) (54) NERVE CELL PROTECTIVE AGENTS MITTEL ZUM SCHUTZ VON NERVENZELLEN AGENTS DE PROTECTION DES CELLULES NERVEUSES (84) Designated Contracting States: • MUKAIHIRA, Takafumi AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC 7, Yotsuya 1-chome Shinjuku-ku Tokyo 160 (JP) NL PT SE • AKADA, Yasushige 7, Yotsuya 1-chome Shinjuku-ku Tokyo 160 (JP) (30) Priority: 30.05.1996 JP 15898596 28.11.1996 JP 33276496 (74) Representative: Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät (43) Date of publication of application: Maximilianstrasse 58 19.08.1998 Bulletin 1998/34 80538 München (DE) (73) Proprietor: MOCHIDA PHARMACEUTICAL CO., (56) References cited: LTD. EP-A- 0 506 363 EP-A- 0 737 670 Shinjuku-ku, Tokyo 160-0004 (JP) JP-A- 4 211 652 JP-A- 7 188 166 JP-A- 8 291 121 (72) Inventors: • YAMAMOTO, Ichiro • GARRATT,P.J. ET AL.: "Mapping the Melatonin Mochida Pharmaceutical Co., Ltd. Receptor. 3. Design and Synthesis of Melatonin Shinjuku-ku Tokyo 160 (JP) Agonists and Antagonists Derived from • ITOH, Manabu Mochida Pharmaceutical Co., Ltd.
    [Show full text]
  • Medical Marijuana Laws
    Financial Impact Estimating Conference Use of Marijuana for Certain Medical Conditions Serial Number 13‐02 Reference Materials Financial Impact Estimating Conference Use of Marijuana for Certain Medical Conditions Serial Number 13‐02 Table of Contents Official Notification ................................................................................................................................ Tab 1 Statutory Authorization for FIEC ............................................................................................................ Tab 2 Information on States with Medical Marijuana Laws ............................................................................ Tab 3 Congressional Research Service Report ................................................................................................. Tab 4 Government Accountability Office Report ............................................................................................ Tab 5 Registrant Characteristics by State ........................................................................................................ Tab 6 2013 Session Legislation ........................................................................................................................ Tab 7 Florida Department of Health Preliminary Analysis .............................................................................. Tab 8 Draft – Summary of Initiative Financial Information Statement ........................................................... Tab 9 Analysis Data .......................................................................................................................................
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0076019 A1 Tyers Et Al
    US 20090076019A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0076019 A1 Tyers et al. (43) Pub. Date: Mar. 19, 2009 (54) METHODS FOR TREATING Publication Classification NEUROLOGICAL DISORDERS OR DAMAGE (51) Int. Cl. Inventors: Mike Tyers, Toronto (CA); Phedias A63/496 (2006.01) (75) CI2O 1/02 (2006.01) Diamandis, Toronto (CA); Peter B. A6II 3/445 (2006.01) Dirks, Toronto (CA) A63/64 (2006.01) Correspondence Address: A6IP 25/00 (2006.01) HOWSON AND HOWSON A6IP 25/6 (2006.01) SUITE 210,501 OFFICE CENTER DRIVE A6IP 25/18 (2006.01) FT WASHINGTON, PA 19034 (US) (52) U.S. Cl. ...................... 514/252.13:435/29: 514/317; 514f613 (73) Assignees: Mount Sinai Hospital, Toronto (CA); HSC Research and Development Limited (57) ABSTRACT Partnership, Toronto (CA) A clonogenic neurosphere assay is described that carries out high throughput screens (HTS) to identify potent and/or (21) Appl. No.: 11/871,562 selective modulators of proliferation, differentiation and/or renewal of neural precursor cells, neural progenitor cells and/ (22) Filed: Oct. 12, 2007 or self-renewing and multipotent neural stem cells (NSCs). Compositions comprising the identified modulators and Related U.S. Application Data methods of using the modulators and compositions, in par (60) Provisional application No. 60/851,615, filed on Oct. ticular to treat neurological disorders (e.g. brain or CNS can 13, 2006. cer) or damage are also disclosed. Neurosphere Stein Progenitor Differentiated eEE eEE t Prolifefatic Assay Patent Application Publication Mar. 19, 2009 Sheet 1 of 26 US 2009/0076019 A1 Figure 1 Neurosphere Progenitor O Defeitiated e CE M.
    [Show full text]
  • Cannabinoids As Therapeutics.Pdf
    (( 3. Umbruch 4.4..2005 )) Milestones in Drug Therapy MDT Series Editors Prof. Michael J. Parnham, PhD Prof. Dr. J. Bruinvels Senior Scientific Advisor Sweelincklaan 75 PLIVA Research Institute Ltd NL-3723 JC Bilthoven Prilaz baruna Filipovic´a 29 The Netherlands HR-10000 Zagreb Croatia Cannabinoids as Therapeutics Edited by R. Mechoulam Birkhäuser Verlag Basel · Boston · Berlin Editor Raphael Mechoulam Medical Faculty Hebrew University Ein Kerem, Jerusalem 91010 Israel Advisory Board J.C. Buckingham (Imperial College School of Medicine, London, UK) R.J. Flower (The William Harvey Research Institute, London, UK) G. Lambrecht (J.W. Goethe Universität, Frankfurt, Germany) P. Skolnick (DOV Pharmaceutical Inc., Hackensack, NJ, USA) A CIP catalogue record for this book is available from the Library of Congress, Washington, D.C., USA Bibliographic information published by Die Deutsche Bibliothek Die Deutsche Bibliothek lists this publication in the Deutsche Nationalbibliografie; detailed biblio- graphic data is available in the internet at http://dnb.ddb.de ISBN 3-7643-7055-6 Birkhäuser Verlag, Basel - Boston - Berlin The publisher and editor can give no guarantee for the information on drug dosage and administration contained in this publication. The respective user must check its accuracy by consulting other sources of reference in each individual case. The use of registered names, trademarks etc. in this publication, even if not identified as such, does not imply that they are exempt from the relevant protective laws and regulations or free for general use. This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, re-use of illustrations, recitation, broad- casting, reproduction on microfilms or in other ways, and storage in data banks.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,058,243 B2 Tyers Et Al
    USOO8058243B2 (12) United States Patent (10) Patent No.: US 8,058,243 B2 Tyers et al. (45) Date of Patent: Nov. 15, 2011 (54) METHOD FORTREATING A BRAIN CANCER Corcoran et al., “A mouse model for medulloblastoma and basal cell WITH IFENPRODIL nevus syndrome” J. Neuro-oncol., 53(3):307-318 (Jul. 2001). Dalton et al., “Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993.” (75) Inventors: Mike Tyers, Toronto (CA); Phedias Am. J. Epidemiol. 155(12): 1088-1095 (Jun. 15, 2002). Diamandis, Toronto (CA); Peter B. Dalton et al., “Risk for cancer in a cohort of patients hospitalized for Dirks, Toronto (CA) schizophrenia in Denmark, 1969-1993.” Schizophr. Res., 75(2- 3):315-324 (Jun. 15, 2005; e-pub: Dec. 13, 2004). (73) Assignees: HSC Research and Development Ding et al., “A role for chemistry in stem cell biology” Nat. Limited Partnership (CA); Mount Biotechnol. 22(7):833-840 (Jul 2004; e-pub: Jun. 30, 2004). Sinai Hospital (CA) Diamandis et al., "Chemical genetics reveals a complex functional ground state of neural stem cells' Nat. Chem. Biol. 3(5):268-273 (*) Notice: Subject to any disclaimer, the term of this (May 2007; e-pub: Apr. 8, 2007). patent is extended or adjusted under 35 Encinas et al., “Fluoxetine targets early progenitor cells in the adult brain” Proc. Natl. Acad. Sci. USA, 103(21):8233-8238 (May 23, U.S.C. 154(b) by 604 days. 2006; e-pub: May 15, 2006). Enver et al., “Loops, lineage, and leukemia' Cell, 94(1):9-12 (Jul.
    [Show full text]